UBTECH ROBOTICS (09880) plans to invest 300 million yuan to establish a partnership enterprise to carry out investments in the intelligent Siasun Robot & Automation industry chain sector.

20:27 22/01/2026

UBTECH (09880) announced on January 22, 2026, that the company has entered into a partnership agreement with Liuzhou Equity Fund and Liuzhou Industry Guidance Fund. According to the agreement, the contracting parties agree to establish a partnership enterprise to invest in the field of intelligent robot industry chain, leveraging the existing industrial base of Liuzhou city. According to the terms of the partnership agreement, the total capital contribution of all partners in the partnership enterprise is 660 million yuan, with Liuzhou Equity Fund contributing 5 million yuan, Liuzhou Industry Guidance Fund contributing 355 million yuan, and the company contributing 300 million yuan. Liuzhou Equity Fund acts as the general partner and fund manager of the partnership enterprise.

UBTECH ROBOTICS (09880) announced that on January 22, 2026, the company entered into a partnership agreement with Liuzhou Industrial Control Fund and Liuzhou Industry Guidance Fund. According to this agreement, the contracting parties agreed to establish a partnership enterprise to invest in the intelligent Siasun Robot & Automation industry chain relying on the existing industrial base in Liuzhou City. Under the terms of the partnership agreement, the total capital contribution of all partners in the partnership enterprise is 660 million RMB, with Liuzhou Industrial Control Fund contributing 5 million RMB, Liuzhou Industry Guidance Fund contributing 355 million RMB, and the company contributing 300 million RMB. Liuzhou Industrial Control Fund serves as the general partner and fund manager of the partnership enterprise. The purpose of the partnership enterprise is to focus on the intelligent Siasun Robot & Automation industry chain, leveraging the existing industrial base in Liuzhou City to invest in the upstream and downstream industries, core components, and intelligent infrastructure, aiming to create a new highland for artificial intelligence and Siasun Robot & Automation industry. The partnership enterprise was jointly established by all partners to create reasonable economic returns through investment portfolios for its partners. The establishment of the partnership enterprise aims to utilize the management capabilities of a professional fund team, integrate resources from multiple parties, and explore high-growth potential projects. The company collaborates with professional investment institutions and government venture capital platforms to build an investment fund platform in the form of an industrial fund, focusing on the intelligent humanoid Siasun Robot & Automation industry chain and investing in the industrial upstream and downstream, core components, and intelligent physical infrastructure, to keep pace with industry trends and expand business opportunities.

LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.

LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.

MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.

LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.

LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.

MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.